nach oben

Current Urology Reports

Erschienen in:

01.08.2014 | Female Urology (K Kobashi, Section Editor)

Management of Recurrent Stress Incontinence Following a Sling

verfasst von: Geneviève Nadeau, Sender Herschorn

Erschienen in: Current Urology Reports | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Management of recurrent or persistent stress urinary incontinence (RSI) following primary insertion of a synthetic midurethral sling (MUS) remains a challenge for the urologist since no consensus is available to favor one treatment over another. Complete workup should be carried out, including cystoscopy, urodynamics and potentially a pelvic floor ultrasound as a diagnostic adjunct. Various surgical options have been described for RSI, apart from another MUS, including tightening of or shortening a previously placed MUS, a mini-sling, a salvage spiral sling, a colposuspension, the ACT® system, an artificial urinary sphincter or ultimately a urinary diversion. Treatment depends ultimately on the experience and the expertise of the surgeon but it appears most reasonable to offer a repeat MUS (retropubic or transobturator), a pubovaginal sling or bulking agents to women with RSI. Appropriate counseling of patients to set realistic outcomes is key as it may be more practical to aim more for symptomatic improvement than cure.

Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78.PubMedCrossRef

Luber KM. The definition, prevalence, and risk factors for stress urinary incontinence. Rev Urol. 2004;6 Suppl 3:S3–9.PubMedCentralPubMed

Goebel R. Zur operativen Beseitgung der angeborenen Incontinentia Vesicae. Dtsch Gynakol Urol. 1910;2:187–91.

Ulmsten U, Henriksson L, Johnson P, Varhos G. An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 1996;7(2):81–5. discussion 85-86.PubMedCrossRef

de Leval J. Novel surgical technique for the treatment of female stress urinary incontinence: transobturator vaginal tape inside-out. Eur Urol. 2003;44(6):724–30.PubMedCrossRef

Delorme E. [Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women]. Prog Urol. 2001;11(6):1306–13.PubMed

Molden SM, Lucente VR. New minimally invasive slings: TVT Secur. Curr Urol Rep. 2008;9(5):358–61.PubMedCrossRef

FDA US. Considerations about surgical mesh for SUI. 2013; http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/ucm345219.htm. Accessed 20 Jan 2014.

Tseng LH, Wang AC, Lin YH, Li SJ, Ko YJ. Randomized comparison of the suprapubic arc sling procedure vs tension-free vaginal taping for stress incontinent women. Int Urogynecol J Pelvic Floor Dysfunct. 2005;16(3):230–5.PubMedCrossRef

10.

Deval B, Ferchaux J, Berry R, et al. Objective and subjective cure rates after trans-obturator tape (OBTAPE) treatment of female urinary incontinence. Eur Urol. 2006;49(2):373–7.PubMedCrossRef

11.

Delorme E, Droupy S, de Tayrac R, Delmas V. Transobturator tape (Uratape): a new minimally-invasive procedure to treat female urinary incontinence. Eur Urol. 2004;45(2):203–7.PubMedCrossRef

12.

Heinonen P, Ala-Nissilä S, Kiilholma P, Laurikainen E. Tension-free vaginal tape procedure without preoperative urodynamic examination: long-term outcome. Int J Urol. 2012;19(11):1003–9.PubMedCrossRef

13.

Novara G, Ficarra V, Boscolo-Berto R, Secco S, Cavalleri S, Artibani W. Tension-free midurethral slings in the treatment of female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials of effectiveness. Eur Urol. 2007;52(3):663–78.PubMedCrossRef

14.

Smith A, Dmochowski R, Hilton P, et al. Surgery for urinary incontinence in women. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence—4th international consultation. 2009th ed. Paris: Health Publications; 2009. p. 1191–272.

15.

Latthe PM, Foon R, Toozs-Hobson P. Transobturator and retropubic tape procedures in stress urinary incontinence: a systematic review and meta-analysis of effectiveness and complications. BJOG. 2007;114(5):522–31.PubMedCrossRef

16.

Barber MD, Kleeman S, Karram MM, et al. Transobturator tape compared with tension-free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstet Gynecol. 2008;111(3):611–21.PubMedCrossRef

17.

Richter HE, Albo ME, Zyczynski HM, et al. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med. 2010;362(22):2066–76.PubMedCentralPubMedCrossRef

18.

FDA Safety Communication. Update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm262435.htm. Accessed 20 Jan 2014.

19.

Lucas MG, Bosch RJ, Burkhard FC, et al. EAU guidelines on surgical treatment of urinary incontinence. Eur Urol. 2012;62(6):1118–29.PubMedCrossRef

20.

SUFU and AUGS position statement on the Mesh MidUrethral Slings (MUS) for the stress urinary incontinence. http://www.sufuorg.com/docs/news/AUGS-SUFU-MUS-Position-Statement-APPROVED-1-3-2014.aspx. http://www.augs.org/p/bl/et/blogid=3&blogaid=28. Accessed 2 Apr 2014.

21.

AUA position statement on the use of vaginal mesh for the surgical treatment of stress urinary incontinence. http://www.auanet.org/about/vaginal-mesh-for-sui.cfm. Accessed 20 Jan 2014.

22.

Stav K, Dwyer PL, Rosamilia A, Schierlitz L, Lim YN, Lee J. Risk factors of treatment failure of midurethral sling procedures for women with urinary stress incontinence. Int Urogynecol J. 2010;21(2):149–55.PubMedCrossRef

23.

Richter HE, Litman HJ, Lukacz ES, et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstet Gynecol. 2011;117(4):913–21.PubMedCentralPubMedCrossRef

24.••

Walsh CA, Moore KH. Recurrent stress urinary incontinence after synthetic midurethral sling procedure. Obstet Gynecol. 2010;115(6):1296–301. Comprehensive review on assessment and management options for recurrent stress incontinence after a failed sling.PubMedCrossRef

25.

Scarpero HM, Dmochowski RR. Sling failures: what's next? Curr Urol Rep. 2004;5(5):389–96.PubMedCrossRef

26.

Dmochowski RR, Blaivas JM, Gormley EA, et al. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol. 2010;183(5):1906–14.PubMedCrossRef

27.

Fialkow M, Symons RG, Flum D. Reoperation for urinary incontinence. Am J Obstet Gynecol. 2008;199(5):546.e541–548.CrossRef

28.

Denman MA, Gregory WT, Boyles SH, Smith V, Edwards SR, Clark AL. Reoperation 10 years after surgically managed pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol. 2008;198(5):555.e551–555.CrossRef

29.

Togami JM, Winters J. Suburethral sling failures and complications. In: Billingham RP, Kobashi K, Peters III WA, editors. Reoperative pelvic surgery. New York: Springer Science + Business Media; 2009. p. 153–63.CrossRef

30.

Schuettoff S, Beyersdorff D, Gauruder-Burmester A, Tunn R. Visibility of the polypropylene tape after tension-free vaginal tape (TVT) procedure in women with stress urinary incontinence: comparison of introital ultrasound and magnetic resonance imaging in vitro and in vivo. Ultrasound Obstet Gynecol. 2006;27(6):687–92.PubMedCrossRef

31.

Dietz HP, Barry C, Lim YN, Rane A. Two-dimensional and three-dimensional ultrasound imaging of suburethral slings. Ultrasound Obstet Gynecol. 2005;26(2):175–9.PubMedCrossRef

32.

Dietz HP. Pelvic floor ultrasound: a review. Am J Obstet Gynecol. 2010;202(4):321–34.PubMedCrossRef

33.

Dietz HP. Ultrasound imaging of the pelvic floor. Part I: two-dimensional aspects. Ultrasound Obstet Gynecol. 2004;23(1):80–92.PubMedCrossRef

34.

Andersson KE, Chapple C, Cardozo L, et al. Pharmacological treatment of urinary incontinence. In: Abrams P, Cardozo L, Khoury S, Wein AJ, eds. 5th International Consultation on Incontinence: ICUD - EAU; 2013:623-728.

35.••

Bakali E, Buckley BS, Hilton P, Tincello DG. Treatment of recurrent stress urinary incontinence after failed minimally invasive synthetic suburethral tape surgery in women. Cochrane Database Syst Rev. 2013;2, CD009407. A Cochrane review underlining the paucity of data to guide management strategies of recurrent incontinence after failed suburethral tape as all RCTs idnetified were ineligible for analysis.PubMed

36.

Lovatsis D, Easton W, Wilkie D, Committee SoOaGoCU. Guidelines for the evaluation and treatment of recurrent urinary incontinence following pelvic floor surgery. J Obstet Gynaecol Can. 2010;32(9):893–904.PubMed

37.

Appell RA, Winters J. Injection therapy for urinary incontinence. In: Wein A, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. Vol 3. 9th ed. Philadelphia: Elsevier Saunders; 2007.

38.

Herschorn S, Steele DJ, Radomski SB. Followup of intraurethral collagen for female stress urinary incontinence. J Urol. 1996;156(4):1305–9.PubMedCrossRef

39.

Bent AE, Tutrone RT, McLennan MT, Lloyd LK, Kennelly MJ, Badlani G. Treatment of intrinsic sphincter deficiency using autologous ear chondrocytes as a bulking agent. Neurourol Urodyn. 2001;20(2):157–65.PubMedCrossRef

40.

Ghoniem G, Corcos J, Comiter C, Bernhard P, Westney OL, Herschorn S. Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled, single-blind study. J Urol. 2009;181(1):204–10.PubMedCrossRef

41.•

Lee HN, Lee YS, Han JY, Jeong JY, Choo MS, Lee KS. Transurethral injection of bulking agent for treatment of failed mid-urethral sling procedures. Int Urogynecol J. 2010;21(12):1479–83. Small study evaluating Macroplastique and Durasphere for recurrent or persistent stress incontinence after a failed sling. Authors found a cure rate of 35 % but satisfactory rate of 77 %.PubMedCrossRef

42.

Gumus II, Kaygusuz I, Derbent A, Simavli S, Kafali H. Effect of the Macroplastique Implantation System for stress urinary incontinence in women with or without a history of an anti-incontinence operation. Int Urogynecol J. 2011;22(6):743–9.PubMedCrossRef

43.

Villet R, Ercoli A, Atallah D, Hoffmann P, Salet-Lizee D. Second tension-free vaginal tape procedure and mesh retensioning: two possibilities of treatment of recurrent-persistent genuine stress urinary incontinence after a primary tension-free vaginal tape procedure. Int Urogynecol J Pelvic Floor Dysfunct. 2002;13(6):377–9.PubMedCrossRef

44.

Feyeux C, Mourtialon P, Guyomard A, Astruc K, Douvier S, Delorme E. [Plication of suburethral slings as treatment of persisting or recurring stress urinary incontinence]. Prog Urol. 2012;22(16):1033–8.PubMedCrossRef

45.

Han JY, Moon KH, Park CM, Choo MS. Management of recurrent stress urinary incontinence after failed midurethral sling: tape tightening or repeat sling? Int Urogynecol J. 2012;23(9):1279–84.PubMedCrossRef

46.

Miranne JM, Hampton BS, Sung VW. Midurethral sling shortening for persistent stress urinary incontinence. Int Urogynecol J. 2012;23(6):805–7.PubMedCrossRef

47.••

Han JY, Lee K, Choo MS. management of recurrent or persistent stress urinary incontinence after mid-urethral sling. LUTS Lower Urinary Tract Symptoms. 2012;4(Supplement S1):95–101. Extensive literature overview of the various surgical procedures available and described for women with recurrent or persistent SUI after initial MUS.CrossRef

48.

Liapis A, Bakas P, Creatsas G. Tension-free vaginal tape in the management of recurrent urodynamic stress incontinence after previous failed midurethral tape. Eur Urol. 2009;55(6):1450–5.PubMedCrossRef

49.

Abdel-Fattah M, Ramsay I, Pringle S, et al. Evaluation of transobturator tension-free vaginal tapes in management of women with recurrent stress urinary incontinence. Urology. 2011;77(5):1070–5.PubMedCrossRef

50.••

Pradhan A, Jain P, Latthe PM. Effectiveness of midurethral slings in recurrent stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2012;23(7):831–41. Meta-analysis of the literature to evaluate effectiveness of a second repeat MUS for women with recurrent SUI after a failed primary MUS. Authors found good cure rates (62-100 %) with a slight advantage for the retropubic approach over the transobturator one.PubMedCrossRef

51.

Wilson WJ, Winters J. Is there still a place for the pubovaginal sling at the bladder neck in the era of the midurethral sling? Curr Bladder Dysfunct Rep. 2006;I:83–6.CrossRef

52.

Riachi L, Kohli N, Miklos J. Repeat tension-free transvaginal tape (TVT) sling for the treatment of recurrent stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2002;13(2):133–5. discussion 135.PubMedCrossRef

53.

Sabadell J, Poza JL, Esgueva A, Morales JC, Sánchez-Iglesias JL, Xercavins J. Usefulness of retropubic tape for recurrent stress incontinence after transobturator tape failure. Int Urogynecol J. 2011;22(12):1543–7.PubMedCrossRef

54.

Lenherr SM, Mourtzinos A. Refractory stress urinary incontinence. In: Alhasso MA, ed. Urinary incontinence. InTech; 2012.

55.

Smith AL, Karp DR, Aguilar VC, Davila GW. Repeat versus primary slings in patients with intrinsic sphincter deficiency. Int Urogynecol J. 2013;24(6):963–8.PubMedCrossRef

56.

Stav K, Dwyer PL, Rosamilia A, et al. Repeat synthetic mid urethral sling procedure for women with recurrent stress urinary incontinence. J Urol. 2010;183(1):241–6.PubMedCrossRef

57.

Smith AR, Artibani W, Drake MJ. Managing unsatisfactory outcome after mid-urethral tape insertion. Neurourol Urodyn. 2011;30(5):771–4.PubMedCrossRef

58.

Meyer F, Hermieu JF, Boyd A, et al. Repeat mid-urethral sling for recurrent female stress urinary incontinence. Int Urogynecol J. 2013;24(5):817–22.PubMedCrossRef

59.

Bacsu C HJ, Alhalabi F, Lee D, Dillon B, Zimmern P. Two failed synthetic mid-urethral slings L and now what. International Continence Society Annual Meeting; August 2013; Barcelona, Spain.

60.

Patil A, Moran P, Duckett J, Committee BSoUA. How do urogynaecologists treat failed suburethral slings? Experience from the British Society of Urogynaecology database and literature review. J Obstet Gynaecol. 2011;31(6):514–7.PubMedCrossRef

61.

Blaivas JG. Recurrent stress urinary incontinence: commentary. In: Goldman HBVS, editor. Current clinical urology: female urology: a practical clinical guide. Totowa: Humana Press Inc; 2007. p. 343–4.

62.

Albo ME, Richter HE, Brubaker L, et al. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med. 2007;356(21):2143–55.PubMedCrossRef

63.

Novara G, Artibani W, Barber MD, et al. Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur Urol. 2010;58(2):218–38.PubMedCrossRef

64.

Rehman H, Bezerra CC, Bruschini H, Cody JD. Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst Rev. 2011;1, CD001754.PubMed

65.

Ogah J, Cody JD, Rogerson L. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2009;4, CD006375.PubMed

66.

Groutz A, Blaivas JG, Hyman MJ, Chaikin DC. Pubovaginal sling surgery for simple stress urinary incontinence: analysis by an outcome score. J Urol. 2001;165(5):1597–600.PubMedCrossRef

67.

Breen JM, Geer BE, May GE. The fascia lata suburethral sling for treating recurrent urinary stress incontinence. Am J Obstet Gynecol. 1997;177(6):1363–5. discussion 1365-1366.PubMedCrossRef

68.

Blaivas JG, Jacobs BZ. Pubovaginal fascial sling for the treatment of complicated stress urinary incontinence. J Urol. 1991;145(6):1214–8.PubMed

69.•

Welk BK, Herschorn S. The autologous fascia pubovaginal sling for complicated female stress incontinence. Can Urol Assoc J. 2012;6(1):36–40. Recent study on 33 patients reporting efficacy of autologous fascia pubovaginal slings after a previous incontinence treatment.PubMedCentralPubMed

70.

Walsh CA, Parkin K, Moore KH. Rectus fascia pubovaginal sling for recurrent stress urinary incontinence after failed synthetic mid-urethral sling: letter. Can Urol Assoc J. 2012;6(6):429–30.PubMedCentralPubMed

71.

Jeon MJ, Jung HJ, Chung SM, Kim SK, Bai SW. Comparison of the treatment outcome of pubovaginal sling, tension-free vaginal tape, and transobturator tape for stress urinary incontinence with intrinsic sphincter deficiency. Am J Obstet Gynecol. 2008;199(1):76.e71–74.CrossRef

72.

Flisser AJ, Blaivas JG. Outcome of urethral reconstructive surgery in a series of 74 women. J Urol. 2003;169(6):2246–9.PubMedCrossRef

73.

Morgan TO, Westney OL, McGuire EJ. Pubovaginal sling: 4-YEAR outcome analysis and quality of life assessment. J Urol. 2000;163(6):1845–8.PubMedCrossRef

74.

Morgan DM, Dunn RL, Fenner DE, et al. Comparative analysis of urinary incontinence severity after autologous fascia pubovaginal sling, pubovaginal sling and tension-free vaginal tape. J Urol. 2007;177(2):604–8. discussion 608-609.PubMedCrossRef

75.

Petrou SP, Frank I. Complications and initial continence rates after a repeat pubovaginal sling procedure for recurrent stress urinary incontinence. J Urol. 2001;165(6 Pt 1):1979–81.PubMedCrossRef

76.

Rutman MP, Deng DY, Shah SM, Raz S, Rodríguez LV. Spiral sling salvage anti-incontinence surgery in female patients with a nonfunctional urethra: technique and initial results. J Urol. 2006;175(5):1794–8. discussion 1798-1799.PubMedCrossRef

77.

Mourtzinos A, Maher MG, Raz S, Rodríguez LV. Spiral sling salvage anti-incontinence surgery for women with refractory stress urinary incontinence: surgical outcome and satisfaction determined by patient-driven questionnaires. Urology. 2008;72(5):1044–8. discussion 1048-1050.PubMedCrossRef

78.•

Rodriguez AR, Hakky T, Hoffman M, Ordorica R, Lockhart J. Salvage spiral sling techniques: alternatives to manage disabling recurrent urinary incontinence in females. J Urol. 2010;184(6):2429–33. Study on 30 women confirming efficacy of a spiral sling for recurrent stress urinary incontinence.PubMedCrossRef

79.

Mostafa A, Lim CP, Hopper L, Madhuvrata P, Abdel-Fattah M. Single-incision mini-slings versus standard midurethral slings in surgical management of female stress urinary incontinence: an updated systematic review and meta-analysis of effectiveness and complications. Eur Urol. 2013.

80.

Verbrugghe A, De Ridder D, Van der Aa F. A repeat mid-urethral sling as valuable treatment for persistent or recurrent stress urinary incontinence. Int Urogynecol J. 2013;24(6):999–1004.PubMedCrossRef

81.

Song PH, Hyun C, Shin E, Jung HC. Effects of the REMEEX System in female patients with intrinsic sphincteric deficiency and recurrent urinary incontinence: 3-year outcomes. LUTS Lower Urinary Tract Symptoms. 2012;4(3):120–5.CrossRef

82.

Errando C, Rodriguez-Escovar F, Gutierrez C, Baez C, Araño P, Villavicencio H. A re-adjustable sling for female recurrent stress incontinence and sphincteric deficiency: outcomes and complications in 125 patients using the Remeex sling system. Neurourol Urodyn. 2010;29(8):1429–32.PubMedCrossRef

83.

Schmid C, Bloch E, Amann E, Mueller MD, Kuhn A. An adjustable sling in the management of recurrent urodynamic stress incontinence after previous failed midurethral tape. Neurourol Urodyn. 2010;29(4):573–7.PubMed

84.

Palma P, Riccetto C, Herrmann V, Dambros M, Fraga R, Grossi O. Transobturator crossover readjustable sling for severe female incontinence: technique and preliminary results. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18(11):1277–82.PubMedCrossRef

85.

Lapitan MC, Cody DJ, Grant AM. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2005;3, CD002912.PubMed

86.

Tanagho EA. Colpocystourethropexy: the way we do it. J Urol. 1976;116(6):751–3.PubMed

87.

Giarenis I, Mastoroudes H, Cardozo L, Robinson D. What do we do when a midurethral tape fails? Rediscovery of open colposuspension as a salvage continence operation. Int Urogynecol J. 2012;23(8):1117–22.PubMedCrossRef

88.

De Cuyper EM, Ismail R, Maher CF. Laparoscopic Burch colposuspension after failed sub-urethral tape procedures: a retrospective audit. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(5):681–5.PubMedCrossRef

89.

Galloway NT, Aboseif S, Sassani P, Franke EI, Nash SD, Slutsky JN, et al. Five years follow-up of adjustable continence therapy (ACT) in the treatment of recurrent female SUI. Open J Urol. 2013;3:132–7.CrossRef

90.

Chartier-Kastler E, Costa P, Ben Naoum K, Cour F, Le Normand L, Haab F. French multicentre prospective study of the use of ACT balloons (Uromedica, Inc., Plymouth, Min, U.S.A.; Medtronic, Minneapolis, U.S.A.) for the treatment of female stress urinary incontinence. Prog Urol. 2007;17(7):1372–7.PubMedCrossRef

91.

Vayleux B, Luyckx F, Thélu S, et al. [Adjustable continence therapy in women, middle term follow-up and a new technique for balloon positioning]. Prog Urol. 2010;20(7):520–6.PubMedCrossRef

92.

Aboseif SR, Franke EI, Nash SD, et al. The adjustable continence therapy system for recurrent female stress urinary incontinence: 1-year results of the North America Clinical Study Group. J Urol. 2009;181(5):2187–91.PubMedCrossRef

93.

Kocjancic E, Crivellaro S, Smith JJ, Ranzoni S, Bonvini D, Frea B. Adjustable continence therapy for treatment of recurrent female urinary incontinence. J Endourol. 2008;22(7):1403–7.PubMedCrossRef

94.

Kocjancic E, Crivellaro S, Ranzoni S, Bonvini D, Grosseti B, Frea B. Adjustable continence therapy for severe intrinsic sphincter deficiency and recurrent female stress urinary incontinence: long-term experience. J Urol. 2010;184(3):1017–21.PubMedCrossRef

95.

Wachter J, Henning A, Roehlich M, Marszalek M, Rauchenwald M, Madersbacher S. Adjustable continence therapy for female urinary incontinence: a minimally invasive option for difficult cases. Urol Int. 2008;81(2):160–6.PubMedCrossRef

96.

Aboseif SR, Sassani P, Franke EI, et al. Treatment of moderate to severe female stress urinary incontinence with the adjustable continence therapy (ACT) device after failed surgical repair. World J Urol. 2011;29(2):249–53.PubMedCrossRef

97.

Nacir M, Ballanger P, Donon L, et al. [ACT device: what place in the treatment of female urinary incontinence?]. Prog Urol. 2013;23(4):276–82.PubMedCrossRef

98.

Phé V, Nguyen K, Rouprêt M, Cardot V, Parra J, Chartier-Kastler E. A systematic review of the treatment for female stress urinary incontinence by ACT(®) balloon placement (Uromedica, Irvine, CA, USA). World J Urol. 2013.

99.

Phé V, Rouprêt M, Mozer P, Chartier-Kastler E. Trends in the landscape of artificial urinary sphincter implantation in men and women in France over the past decade. Eur Urol. 2013;63(2):407–8.PubMedCrossRef

100.

National Collaborating Centre for Women’s and Children’s Health. Urinary incontinence in women: the management of urinary incontinence in women. Commissioned by the National Institute for Health and Clinical Excellence. Second Edition ed. London: Royal College of Obstetricians and Gynaecologists; February 2013.

101.

Poinas G, Droupy S, Ben Naoum K, et al. [Treatment of women urinary incontinence by artificial urinary sphincter: efficacy, complications and survival]. Prog Urol. 2013;23(6):415–20.PubMedCrossRef

102.••

Lipp A, Shaw C, Glavind K. Mechanical devices for urinary incontinence in women. Cochrane Database Syst Rev. 2011;7, CD001756. Cochrane review of the RCTs comparing the effect of mechanical devices in the management of adult female urinary incontinence. The authors found insufficient evidence in favour of one device over another and little evidence comparing them to other forms of treatment.PubMed

103.

Smith TCD, Dmochowski R, et al. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence, 4th international consultation on incontinence. Plymouth: Plymbridge Distributors; 2009. p. 1273–320.

104.

Cox R, Worth PH. Ileal loop diversion in women with incurable stress incontinence. Br J Urol. 1987;59(5):420–2.PubMedCrossRef

105.

Gräs S, Lose G. The clinical relevance of cell-based therapy for the treatment of stress urinary incontinence. Acta Obstet Gynecol Scand. 2011;90(8):815–24.PubMedCrossRef

106.•

Carr LK, Robert M, Kultgen PL, et al. Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study. J Urol. 2013;189(2):595–601. Multi-institutional feasbility study among 38 women followed for 12 months and treated with intrasphincter injection of autologous muscle derived cells. Authors found treatment appears safe with apparent efficacy to relieve SUI symptoms.PubMedCrossRef

107.

Sèbe P, Doucet C, Cornu JN, et al. Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study. Int Urogynecol J. 2011;22(2):183–9.PubMedCrossRef

Titel: Management of Recurrent Stress Incontinence Following a Sling
verfasst von: Geneviève Nadeau
Sender Herschorn
Publikationsdatum: 01.08.2014
Verlag: Springer US
Erschienen in: Current Urology Reports / Ausgabe 8/2014
Print ISSN: 1527-2737
Elektronische ISSN: 1534-6285
DOI: https://doi.org/10.1007/s11934-014-0427-0

Neu im Fachgebiet Urologie

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2014

Botulinum Toxin A’s Expanding Role in the Management of Pediatric Lower Urinary Tract Dysfunction

Challenges and Future Prospects for Tissue Engineering in Female Pelvic Medicine and Reconstructive Surgery

Management of Failed Stress Urinary Incontinence Surgery

Graft Surgery in Extensive Urethral Stricture Disease